LGVN
Longeveron Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.78
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.55x
- Price / sales
- 4.78x
- Price / cash flow
- -0.28x
Enterprise value
- Enterprise value
- -$3.8M
- EV / sales
- -3.22x
- EV / EBITDA
- 0.17x
- EV / EBIT
- 0.16x
- Market cap
- $5.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026